Skip to main content
Equibles

FCPM III SERVICES B.V.

Position in REPL — Replimune Group, Inc.

CIK 2013410 NAARDEN, P7
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$31,088,633
+$9,604,618 QoQ
Shares Held
2,808,368
0.0% QoQ
Ownership
2.98%
of shares outstanding
% of Portfolio
4.15%
of 13F equity value
Holder Rank
#10
of 199 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FCPM III SERVICES B.V. holds $749,575,144 across 10 Biotechnology names. REPL ranks #6 (4.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NAMS
NewAmsterdam Pharma Co N.V.
 8,490,353 $287,738,062
2 MPLT
MapLight Therapeutics, Inc.
 3,226,400 $115,634,176
3 DYN
Dyne Therapeutics, Inc.
 3,848,256 $85,469,765
4 VOR
Vor Biopharma Inc.
 4,117,354 $75,800,487
5 DMRA
Damora Therapeutics, Inc.
 2,441,000 $63,490,410
6 REPL
Replimune Group, Inc.
This page 		2,808,368 $31,088,633
7 CBIO
Crescent Biopharma, Inc.
 1,677,852 $30,201,336
8 AURA
Aura Biosciences, Inc.
 4,053,775 $28,781,802

All Filings in REPL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,088,633 2,808,368
2026-03-31 $21,484,015 2,808,368
2025-12-31 $27,297,336 2,808,368
2025-09-30 $17,423,561 4,158,368
2025-06-30 $36,321,075 3,909,696
2025-03-31 $38,119,536 3,909,696
2024-12-31 $48,084,789 3,970,668
2024-09-30 $53,336,281 4,866,449
2024-06-30 $43,798,041 4,866,449
2024-03-31 $39,758,888 4,866,449
2023-12-31 $41,024,586 4,866,499